SEC
CVET

Seven Eight Capital’s Covetrus, Inc. Common Stock CVET Stock Holding History

Seven Eight Capital’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-27,400
Closed -$669K – 684
2020
Q3 		$669K Buy
+27,400
New +$591K 0.14% 273

Other funds holding CVET

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SG
SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return
FCM
Freshford Capital Management Rye Brook, New York $200M AUM 31.49% 1-Year Est. Return

Seven Eight Capital's CVET Position: Q4 2020 in Review

Seven Eight Capital sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2020, closing a stake of 27,400 shares — an estimated $669K sold.

Seven Eight Capital first reported a position in CVET in Q3 2020 and held it in 1 quarter. The position peaked at $669K in Q3 2020. 277 funds tracked by Wall St. Rank hold CVET as of Q4 2020.

  • Seven Eight Capital reported no remaining Covetrus, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Seven Eight Capital sold 27,400 Covetrus, Inc. Common Stock shares in Q4 2020, an estimated $669K.
  • Seven Eight Capital first reported a position in Covetrus, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Seven Eight Capital's Covetrus, Inc. Common Stock position peaked at $669K in Q3 2020.
  • 277 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2020.

Based on Seven Eight Capital's 13F filing for Q4 2020, filed 9 Feb 2021.